Trial Profile
Enhanced Control of Hypertension and Thrombolysis Stroke Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ENCHANTED
- 19 Mar 2021 Results (n= 2588 ) presented at the International Stroke Conference 2021
- 16 Sep 2018 This trial has been completed in Spain.
- 07 Jul 2015 New trial record